1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reply to Letter to the Editor : “Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up”
(
- Contribution to journal › Letter
- 2022
-
Mark
Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
(
- Contribution to journal › Article
- 2018
-
Mark
Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy : translational implications for interventional therapies
(
- Contribution to journal › Article
- 2017
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
- 2016
-
Mark
A genome-wide association study in multiple system atrophy
(
- Contribution to journal › Article
- 2015
-
Mark
Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.
(
- Contribution to journal › Article
- 2013
-
Mark
The natural history of multiple system atrophy: a prospective European cohort study
(
- Contribution to journal › Article
- 2010
-
Mark
Presentation, Diagnosis, and Management of Multiple System Atrophy in Europe: Final Analysis of the European Multiple System Atrophy Registry
(
- Contribution to journal › Article
- 2008
-
Mark
Red flags for multiple system atrophy
(
- Contribution to journal › Article